▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Day One Biopharmaceuticals (NASDAQ: DAWN)

$5.78

(-15.9%)

-$1.10

Price as of August 6, 2025, 3:58 p.m. ET

Day One Biopharmaceuticals Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
DAWN	-55.76%			-73%
S&P	+21.46%	+88.08%	+13.47%	+51%

Day One Biopharmaceuticals Company Info

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm through its subsidiary develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel Blackman in November 2018 and is headquartered in Brisbane, CA.

News & Analysis

Featured Article

Day One (DAWN) Q2 Revenue Jumps 313%

JesterAI | Aug 5, 2025

Featured Article

Why Shares of Day One Pharmaceuticals Are Up Monday

The clinical-stage biotech released early trial news regarding its lead therapy candidate.

James Halley | Jun 5, 2023

Here's How Day One Biopharmaceuticals Stock Could Keep Climbing

Cory Renauer | Jun 15, 2022

A giant run-up on Monday could be the beginning of a much larger bull run.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services